Enter your terms above and click the 'Search' button.

Showing articles 0 to 14 of 14 Filter Applied: multiple sclerosis,treatment of (Click to remove) Relapse Management in Multiple Sclerosis The Neurologist 15:1-5, Thrower,B.W., 2009 Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA 291:2367-2375, Dalakas,M.C., 2004 European Study on Intravenous Immunoglobulin in Multiple Sclerosis Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004 Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004 Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial Lancet 364:1149-1156, Hommes,O.R.,et al, 2004 IV Immunoglobulins as Add-on Treatment to Methylprednisolone for Acute Relapses in MS Neurol 63:2028-2033, Sorensen,P.S.,et al, 2004 Disease Modifying Therapies in Multiple Sclerosis Neurol 58:169-178, Goodin,D.S.,et al, 2002 Plasma Exchange for Severe Attacks of CNS: Demyelination: Predictors of Response Neurol 58:143-146, Keegan,M.,et al, 2002 Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost? JNNP 70:574-579, Bryan,J.,et al, 2001 Intravenous Immunoglobulin Treatment in Multiple Sclerosis, Effect on Relapses Neurol 50:398-402, Achiron,A.,et al, 1998 Intravenous Immunoglobulin G Reduces MRI Activity in Relapsing Multiple Sclerosis Neurol 50:1273-1281, Sorensen,P.S.,et al, 1998 Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997 Management of Multiple Sclerosis NEJM 337:1604-1611, Rudick,R.A.,et al, 1997 Open Controlled Therapeutic Trial of Intravenous Immune Globulin in Relapsing-Remitting Multiple Sclerosis Arch Neurol 49:1233-1236, Achiron,A.,et al, 1992 Showing articles 0 to 14 of 14